logo

For the Inventor, By the Inventor

Wayland, MA, United States of America

Wei Li

This inventor holds 16 USPTO granted patents and 16 published patent applications and 9 EPO patents. Top assignees: Boston Biomedical, Inc., Sumitomo Dainippon Pharma Oncology, Inc., The Georgia State University Research Foundation, Inc.. Active years: 2012-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Li. Retrieved from https://idiyas.com/inventor/wei-li-gjqvd1nl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 

% Patents Active = 6.3

 

Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 41(Granted Patents)


Company Filing History:

goldMedal13 out of 19 
 
Boston Biomedical, Inc.
 patents
silverMedal2 out of 11 
 
Sumitomo Dainippon Pharma Oncology, Inc.
 patents
bronzeMedal1 out of 205 
 
The Georgia State University Research Foundation, Inc.
 patents

Years Active: 2012-2022

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 11299469 - Naphthofuran derivatives, preparation, and methods of use thereof (2022-04-12),
2. 10851075 - Stat3 pathway inhibitors and cancer stem cell inhibitors (2020-12-01),
3. 10683274 - 3-substituted carbonyl-naphtho[2,3-B]furane derivative or pharmaceutically acceptable salt thereof (2020-06-16),
4. 10646464 - Methods for treating cancer (2020-05-12),
5. 10543189 - 2-acetylnaphtho[2,3-b]furan -4,9-dione for use on treating cancer (2020-01-28),
6. 10017488 - 3-substituted carbonyl-naphtho[2,3-B]furane derivative or pharmaceutically acceptable salt thereof (2018-07-10),
7. 9834532 - Stat3 pathway inhibitors and cancer stem cell inhibitors (2017-12-05),
8. 9745278 - Group of STAT3 pathway inhibitors and cancer stem cell pathway inhibitors (2017-08-29),
9. 9730909 - Methods for targeting cancer stem cells (2017-08-15),
10. 9725444 - Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinases (2017-08-08),
11. 9381184 - Compounds and compositions for targeting cancer stem cells (2016-07-05),
12. 9187454 - Inhibitors of kinases and cancer stem cells, and methods of preparation and use thereof (2015-11-17),
13. 9084766 - Compounds and compositions for targeting cancer stem cells (2015-07-21),
14. 8877803 - Stat3 pathway inhibitors and cancer stem cell inhibitors (2014-11-04),
15. 8303946 - Methods and compositions for inhibition of viral replication (2012-11-06),

Title: Inventor Wei Li: Pioneering Innovations in Wayland

Introduction: Wei Li is a distinguished inventor based in Wayland, MA, known for his groundbreaking contributions to various technological fields.

Latest Patents: Wei Li holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and ingenuity in the innovation landscape.

Career Highlights: With over two decades of experience in research and development, Wei Li has worked for leading tech companies, where he spearheaded projects that have led to significant advancements in the industry.

Collaborations: Wei Li has collaborated with top researchers, engineers, and scientists from renowned universities and research institutions worldwide, fostering a culture of innovation and knowledge exchange.

Conclusion: Wei Li's passion for pushing the boundaries of technology and his relentless pursuit of excellence continue to inspire the next generation of inventors and innovators globally.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…